Severe Churg-Strauss syndrome with mediastinal lymphadenopathy treated with interferon therapy

European Journal of Internal Medicine

Volumn 13, Issue 7, 2002, Pages 458-462

  Lesens, Olivier ^a   Hansmann, Yves ^a   Nerson, Jacques ^b   Pasquali, Jean Louis ^c   Gasser, Bernard ^c   Wihlm, Jean Marie ^c   Christmann, D ^a  

^a HÔPITAL CIVIL   (France)

^b Clinique Adassa   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Churg Strauss syndrome; Interferon alpha; Lymphadenopathy; Mediastinal lymphadenopathy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA2B INTERFERON; BRONCHODILATING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; SANDOGLOBULINE; STEROID; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHURG STRAUSS SYNDROME; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LYMPHADENOPATHY; MEDIASTINUM LYMPH NODE; TREATMENT FAILURE;

EID: 0036789928     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00136-X     Document Type: Article

References (18)

1. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine. 78:1999;26-37.
2. Langford C.A. Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: where do we stand? Arthritis Rheum. 44:(3):2001;666-675.
3. Masi A.T., Hunder G.G., Lie J.T., et al. The American College of Rheumatology 1990 criteria for the classification of the Churg and Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 33:1990;1094-1100.
4. Kaneki T., Kawashima A., Hayano T., et al. Churg-Strauss syndrome (allergic granulomatous angiitis) presenting with ileus caused by ischemic ileal ulcer. J Gastroenterol. 33:(1):1998;112-116.
5. Tsuduki E., Enomoto T., Yoshioka H., et al. Churg-Strauss syndrome with pulmonary eosinophilia and intrapulmonary lymph nodes 2 years before the onset of vasculitis. Nihon Kokyuki Gakkai Zasshi. 37:(10):1999;817-822.
6. Casey M., Radel E., Ratech H. Lymph node manifestations of limited Churg-Strauss syndrome. J Pediatr Hematol Oncol. 22:(5):2000;468-471.
7. Churg A., Brallas M., Cronin S.R., Churg J. Formes frustes of Churg-Strauss syndrome. Chest. 108:1995;320-323.
8. Kreeftenberg H.G. Jr., Ligtenberg J.J., van der Werf T.S., Timens W., Cohen Tervaert J.W. Pulmonary vasculitis may obscure large cell lung carcinoma. A case report. Clin Exp Rheumatol. 19:(06):2001;731-734.
9. Weller P.F., Bubley G.J. The idiopathic hypereosinophilic syndrome. Blood. 83:(10):1994;2759-2779.
10. Broxmeyer H.E., Lu L., Platzer E., Feit C., Juliano L., Rubin B.Y. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol. 131:1983;1300-1305.
11. Morita M., Lamkhioued B., Soussi G., et al. Induction by interferons of human eosinophils apoptosis and regulation by interleukin-3, granulocyte/macrophage colony-stimulating factor and interleukin-5. Eur Cytokine Network. 7:1996;725-732.
12. Nakajima H., Nakao A., Watanabe Y., Yoshida S., Iwamoto I. IFN-alpha inhibits antigen-induced eosinophils and CD4+ T cell recruitment into tissue. J Immunol. 153:1994;1264-1270.
13. Tsukadaira A., Okubo Y., Kitano K., et al. Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc. 20:1999;39-44.
14. Aldebert D., Lamkhioued B., Desaint C., et al. Eosinophils express a functional receptor for interferon α on the release of mediators. Blood. 87:(6):1996;2354-2360.
15. Butterfield J.H., Gleich G.J. Interferon-α treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med. 121:1994;648-653.
16. Tatsis E., Schnabel A., Gross W. Interferon-α treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med. 129:1998;370-374.
17. Termeer C.C., Simon J.C., Schopf E. Low-dose interferon α-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement. Arch Dermatol. 137:2001;136-138.
18. Mercie P., Viallard J.F., Faure I., et al. Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome. J Rheumatol. 27:(3):2000;814-817.